Navigation Links
BioMarin to Host a Research and Development Day on October 19th
Date:10/5/2010

NOVATO, Calif., Oct. 5 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) will host a Research and Development Day for the investment community on Tuesday, October 19, 2010 from 8:00 a.m. to 12:00 p.m. at the St. Regis Hotel in New York City. Members of BioMarin's management team and outside experts will provide an update on the company's product portfolio and advancements in the research and development pipeline.

Interested parties may access a live audio webcast of the presentation via the investor section of the BioMarin website, http://www.BMRN.com. A replay of the presentation will be archived on the site for at least one week following the presentation.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in clinical development for the treatment of MPS IVA and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU. For
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
2. BioMarin to Present at the UBS Global Life Sciences Conference
3. BioMarin to Present at the Stifel Nicolaus Healthcare Conference
4. BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease
5. BioMarin Acquires ZyStor Therapeutics, Inc.
6. BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
7. BioMarin to Acquire LEAD Therapeutics
8. BioMarin to Present at the Credit Suisse Healthcare Conference
9. BioMarin Announces Third Quarter 2009 Financial Results
10. BioMarin to Present at the Oppenheimer Healthcare Conference
11. BioMarin Acquires Huxley Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)...  iMD Companies, Inc. (ICBU) has repositioned itself as a holding ... a foothold in the hydroponic, hemp and medical marijuana sectors. ... in the sector, and recently partnering with the Chippewa Tribe ... medical marijuana, iMD is committing to bring its vision to ...
(Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... has approved a share repurchase program. The open-ended authorization ... of Mallinckrodt plc ordinary shares. "Funding ... top priorities as we continue to pursue a range ...
(Date:1/22/2015)... Jan. 22, 2015  BiOptix is pleased to announce the ... President of Chemistry and Biochemistry. Scott joins the company after ... and Amgen throughout the course of his nearly 20 ... "Scott is a nationally recognized thought leader in the ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... Oct. 21 Laureate Pharma, Inc., a full-service biopharmaceutical ... has signed a new Biopharmaceutical Development and Manufacturing Agreement ... will develop the process to manufacture a unique Fc ... for use in clinical trials. Terms of the manufacturing ...
... Inc. (Amex: UPI ) announced today that it will ... 30, 2009, at the market close on Monday, November 2, ... discuss these results on Monday, November 2, 2009 at 3:30 ... Officer, and Medi Jiwani, Vice President, Chief Financial Officer and ...
Cached Medicine Technology:Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement 2Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative ... design to treat specific body parts and muscle groups. , ... easy to use patented cold therapy machine with the innovative ... and muscle injuries. IsoComforter has become the industry leader ...
(Date:1/22/2015)... 2015 EBSCO Information Services (EBSCO) ... their relationship in an effort to further promote visibility and ... EBSCO has long made AMA journals available via its subscription ... The JAMA Network. , Long known as both ...
(Date:1/22/2015)... has released a new blog post presenting a list of vehicles ... , Some types of vehicles cannot be covered under an ... post to see if their vehicle qualifies for auto insurance coverage. ... the cars that cannot be covered by a plan. Clients have ...
(Date:1/22/2015)... 22, 2015 State Forestry Institute of ... system with support from GEOSYSTEMS, a dedicated Hexagon Geospatial ... will leverage Hexagon Geospatial’s ERDAS APOLLO for ... well as point clouds and documents. This effort will ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... Jan. 22 With a generous donation from Eyre Bus, Tour ... D.C. and New York areas is headed to Haiti ... Haiti Relief Committee (GWHRC) announced today.  The transport of the group is ... 11:30 p.m. tonight. , "On behalf of my father, ...
... OAKLAND , Jan. 23 After months ... hospitals and nursing homes in California , former SEIU-UHW officials ... 29 elections that are ready to proceed for more than 4,000 ... January for misusing union funds and undermining members, democratic rights, formed ...
... study says , FRIDAY, Jan. 22 (HealthDay News) -- If you,re ... to start potty training may be between the second and third ... the ideal window for moving your child out of diapers. Children ... have urge incontinence -- daytime wetting and bed-wetting -- between ages ...
... that having a conversation (for example on a cell phone) ... also true: Driving reduces one,s ability to comprehend and use ... Illinois, appear in the journal Psychonomic Bulletin & Review ... driving impairs language skills, said Gary Dell, a psycholinguist in ...
... of scientists led by Professor Adrian Krainer, Ph.D., of ... cancer cells that boost the production of an enzyme ... altered metabolic state, called the Warburg effect, promotes extremely ... Discovered eighty years ago by Nobel Prize-winning scientist Otto ...
... baby is a joyful experience. But it is not unusual ... depression. Global figures suggest that between 13 and 16 percent ... by depression. For the second birth, figures boost to a ... University of Stavanger in Norway, surveyed 250 postnatal women for ...
Cached Medicine News:Health News:Eyre Bus, Tour & Travel Donates Bus to Transport Medical Professionals from D.C. Area to New York for Flight to Haiti, Announces the Greater Washington Haiti Relief Committee and the Embassy of Haiti 2Health News:Eyre Bus, Tour & Travel Donates Bus to Transport Medical Professionals from D.C. Area to New York for Flight to Haiti, Announces the Greater Washington Haiti Relief Committee and the Embassy of Haiti 3Health News:Latest Twist: Ousted Union Officials Show True Colors By Trying to Stop 29 Union Elections 2Health News:Latest Twist: Ousted Union Officials Show True Colors By Trying to Stop 29 Union Elections 3Health News: Potty Training Best Between Ages 2 and 3 2Health News: Potty Training Best Between Ages 2 and 3 3Health News: Potty Training Best Between Ages 2 and 3 4Health News:Driven to distraction: New study shows driving hinders talking 2Health News:CSHL study identifies potential way to reverse cancer cell metabolism and tumor growth 2Health News:CSHL study identifies potential way to reverse cancer cell metabolism and tumor growth 3Health News:Emotions should be taken seriously 2Health News:Emotions should be taken seriously 3